Charlotte Dahle

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Martin Gunnarsson, Clas Malmeström, Markus Axelsson et al. · Annals of Neurology · 2010 · 337 citations · Full text

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

Anna Lanemo Myhrinder, Eva Hellqvist, E. V. Sidorova et al. · Blood · 2008 · 270 citations · Full text

Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid

Johan Mellergård, Måns Edström, Magnus Vrethem et al. · Multiple Sclerosis Journal · 2009 · 145 citations · Full text

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Irene Håkansson, Anders Tisell, P Cassel et al. · Journal of Neuroinflammation · 2018 · 125 citations · Full text

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis

Irene Håkansson, Anders Tisell, P Cassel et al. · European Journal of Neurology · 2017 · 116 citations